Global Biosimilars Market Size, by Region (2024–2032)

Free

in USD Million

Global Biosimilars Market Outlook: North America to Lead Growth Across Regions (2024-2032)

Published by MMR Statistics Reserch Team, November 2025

Global healthcare dynamics are reshaping regional adoption patterns as innovative biologics gain momentum. The Global Biosimilars Market was valued at USD 13,991.97 million in North America in 2024 and is estimated to reach USD 15,431.02 million in 2025, while Europe grew from USD 11,017.35 million in 2024 to an estimated USD 12,220.02 million in 2025, driven by rising patient access and regulatory support. Asia Pacific adoption is projected to boost the market from USD 5,376.17 million in 2024 to USD 8,775.88 million by 2028, while the Middle East & Africa and South America are expected to contribute to accelerating global growth. By 2032, the Global Biosimilars Market is projected to reach USD 34,335.12 million in North America and USD 15,443.21 million in Asia Pacific, driving regional innovation, enhancing therapeutic reach, and creating sustainable value for healthcare stakeholders worldwide.

OTHER STATISTICS ON TOPIC

Biosimilars

More statistics on Biosimilars

Download

Information

Unit

in USD Million

Region

Global

Time Period

2024-2032

Source Name

Maximize Market Research Pvt. Ltd

Source Link

http://www.maximizemarketresearch.com

Publisher Name

Maximize Market Research Pvt. Ltd

Publisher Link

http://www.maximizemarketresearch.com

Related reports

Market Research Reports on Biosimilars

Explore published research tied to this statistic's topic. Open the featured edition or jump into another region without leaving the page.

Open featured report

Subscriptions

Stay ahead of Biosimilars with tailored access

Sample free-tier statistics or unlock premium coverage for this topic with team-friendly usage rights.

Discover

Try free-tier statistics before committing to a plan.

Start for Free

Professional

Unlock premium coverage across this topic with analyst support.

Select Plan

Contact our team

Need a bespoke deep-dive on Biosimilars?

Tell us about your KPIs and coverage priorities. We can tailor a briefing, share methodology notes, or build a custom dataset that complements the reports and statistics you are browsing.

Talk with an analyst